Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) surged during the extended hours trading after the Centers for Disease Control and Prevention (CDC) confirmed that the first case of Ebola virus was diagnosed in the United States.
Tekmira and other pharmaceutical stocks climb
The stock price of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) climbed 22.89%% to $25.90 per share at the time of this writing, around 5:36 P.M. in New York.
It's no secret that this year has been a volatile one for the markets. The S&P 500 is down 18% year to date, while the Nasdaq Composite is off by 27% year to date. Meanwhile, the VIX, a key measure of volatility, is up 49% year to date at 24.72. However, it has spiked as Read More
The shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) and Sarepta Therapeutics Inc (NASDAQ:SRPT) also rallied 12.47% to $11 per share and 6.30% to $22.65 per share at the time of this writing.
Yesterday, Texas Health Presbyterian Hospital of Dallas issued a statement that a patient was placed in a “strict isolation” and was tested for Ebola virus due to his symptom and recent travel history.